These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1402213)
61. A prostacyclin-sparing effect of indobufen vs. aspirin. De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417 [TBL] [Abstract][Full Text] [Related]
62. Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial. Gao XY; Liu YM; Zheng DN; Li YW; Li H; Xiong XL; Chen HY; Wang H; Yu XY; Qu K; Jin J; Lin B; He Q Ren Fail; 2023 Dec; 45(1):2163505. PubMed ID: 36636998 [TBL] [Abstract][Full Text] [Related]
65. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
66. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year]. Rohn V; Pirk J; Mach T Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942 [TBL] [Abstract][Full Text] [Related]
67. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387 [TBL] [Abstract][Full Text] [Related]
68. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Cataldo G; Heiman F; Lavezzari M; Marubini E Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928 [TBL] [Abstract][Full Text] [Related]
69. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass. Rychlik IJ; Davey P; Murphy J; O'Donnell ME J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288 [TBL] [Abstract][Full Text] [Related]
70. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass. D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213 [TBL] [Abstract][Full Text] [Related]
71. Indobufen: an updated review of its use in the management of atherothrombosis. Bhana N; McClellan KJ Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445 [TBL] [Abstract][Full Text] [Related]